Managers / Q4 2021 · view latest →
Telemetry Investments, L.L.C.
CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700
Reported Value
$78M
Q4 2021
Positions
178
Filings on Record
17
2019–present window
Filed
Feb 14, 2022
original filing
Summary
Telemetry Investments, L.L.C. reported $78M in U.S.-listed holdings across 178 positions for Q4 2021.
Its largest position, IWM, represents 7.1% of the portfolio.
Compared with Q3 2021, the fund opened 73 new positions and exited 56.
Portfolio Metrics
Turnover
+40.1%
vs prior filed quarter
Top-10 Concentration
+30.6%
share of reported value
Largest Position
+7.1%
Ishares Tr
New / Exited
73 / 56
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 39.9% · $31M
- Other · 39.0% · $30M
- ETP · 15.2% · $12M
- ADR · 4.7% · $4M
- REIT · 0.9% · $713,000
- Equity WRT · 0.3% · $199,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| QQQINVESCO QQQ TR | NEW | +5.0K | 5.0K | +$2M | $2M |
| HEALTHWELL ACQUISITION CORP | NEW | +192.8K | 192.8K | +$2M | $2M |
| XBISPDR SER TR | NEW | +10.0K | 10.0K | +$1M | $1M |
| TRAJECTORY ALPHA ACQUISITION | NEW | +105.0K | 105.0K | +$1M | $1M |
| HOME PLATE ACQUISITION CORP | NEW | +101.0K | 101.0K | +$977,000 | $977,000 |
| SOUTHPORT ACQUISITION CORP | NEW | +80.1K | 80.1K | +$801,000 | $801,000 |
| FUTURE HEALTH ESG CORP | NEW | +77.9K | 77.9K | +$761,000 | $761,000 |
| BIOPLUS ACQUISITION CORP | NEW | +75.5K | 75.5K | +$755,000 | $755,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2021
158 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IWMISHARES TR | RUSSELL 2000 ETF · CHINA LG-CAP ETF · MSCI EURO FL ETF · MSCI INDIA ETF · MSCI EMG MKT ETF · MSCI CHINA ETF | 7.14% | $6M | 84.5K |
| 2 | ANGEL POND HOLDINGS CORP | SHS CL A · *W EXP 99/99/999 | 3.80% | $3M | 401.7K |
| 3 | SILVER SPIKE ACQUISITN CORP | CLASS A ORD SHS · *W EXP 02/26/202 | 3.57% | $3M | 336.2K |
| 4 | XILINX INC | COM | 3.33% | $3M | 12.2K |
| 5 | QQQINVESCO QQQ TRhistory → | UNIT SER 1 | 2.56% | $2M | 5.0K |
| 6 | HEALTHWELL ACQUISITION CORP | CLASS A COM · *W EXP 08/05/202 | 2.48% | $2M | 289.2K |
| 7 | XBISPDR SER TR | S&P BIOTECH · S&P METALS MNG | 2.13% | $2M | 22.0K |
| 8 | IHS MARKIT LTD | SHS | 2.09% | $2M | 12.2K |
| 9 | EIGER BIOPHARMACEUTICALS INC | COM | 1.77% | $1M | 265.0K |
| 10 | ATYRATYR PHARMA INChistory → | COM NEW | 1.70% | $1M | 176.8K |
| 11 | STATE AUTO FINL CORP | COM | 1.66% | $1M | 24.9K |
| 12 | PARATEK PHARMACEUTICALS INC | COM | 1.52% | $1M | 262.3K |
| 13 | COHERENT INC | COM | 1.46% | $1M | 4.3K |
| 14 | TRAJECTORY ALPHA ACQUISITION | UNIT 99/99/9999 | 1.34% | $1M | 105.0K |
| 15 | CCITIGROUP INChistory → | COM NEW | 1.33% | $1M | 17.0K |
| 16 | HOME PLATE ACQUISITION CORP | CL A COM · *W EXP 09/30/202 | 1.29% | $1M | 151.5K |
| 17 | WTWWILLIS TOWERS WATSON PLC LTDhistory → | SHS | 1.28% | $997,000 | 4.2K |
| 18 | DISDISNEY WALT COhistory → | COM | 1.28% | $991,000 | 6.4K |
| 19 | FEZSPDR INDEX SHS FDShistory → | EURO STOXX 50 | 1.20% | $933,000 | 20.0K |
| 20 | AFFIMED N V | COM | 1.07% | $829,000 | 150.3K |
| 21 | GANXGAIN THERAPEUTICS INChistory → | COM | 1.04% | $807,000 | 151.1K |
| 22 | SOUTHPORT ACQUISITION CORP | UNIT 99/99/9999 | 1.03% | $801,000 | 80.1K |
| 23 | FUTURE HEALTH ESG CORP | COM · *W EXP 99/99/999 | 1.00% | $780,000 | 116.9K |
| 24 | BACBK OF AMERICA CORP | COM | 0.98% | $761,000 | 17.1K |
| 25 | BIOPLUS ACQUISITION CORP | UNIT 12/02/2026 | 0.97% | $755,000 | 75.5K |
| 26 | HEALTHCARE AI ACQUISITION CO | UNIT 12/07/2026 | 0.97% | $751,000 | 75.0K |
| 27 | EVAXION BIOTECH A S | ADS | 0.95% | $740,000 | 167.5K |
| 28 | STONEBRIDGE ACQUISITION CORP | CLASS A ORD SHS · *W EXP 03/31/202 | 0.95% | $738,000 | 109.7K |
| 29 | WELBILT INC | COM | 0.95% | $737,000 | 31.0K |
| 30 | MIRMIRION TECHNOLOGIES INC | COM CL A | 0.92% | $717,000 | 68.5K |
| 31 | INTELLIGENT MEDI ACQSITN COR | UNIT 11/05/2026 | 0.92% | $713,000 | 69.9K |
| 32 | BABAALIBABA GROUP HLDG LTD | SPONSORED ADS | 0.92% | $713,000 | 6.0K |
| 33 | PEOPLES UNITED FINANCIAL INC | COM | 0.91% | $706,000 | 39.6K |
| 34 | FAST ACQUISITION CORP II | CL A | 0.91% | $703,000 | 72.4K |
| 35 | PERSHING SQUARE TONTINE HLDG | COM CL A | 0.86% | $670,000 | 34.0K |
| 36 | ACTIVISION BLIZZARD INC | COM | 0.86% | $665,000 | 10.0K |
| 37 | GWBGREAT WESTERN BANCORP INC | COM | 0.81% | $630,000 | 18.5K |
| 38 | VEONEER INC | COM | 0.80% | $624,000 | 17.6K |
| 39 | AMRYT PHARMA PLC | SPONSORED ADS | 0.79% | $610,000 | 56.5K |
| 40 | SOFTWARE ACQUISITN GRP INC I | COM CL A · *W EXP 02/02/202 | 0.77% | $601,000 | 88.9K |
| 41 | BLOCKCHAIN COINVSTRS ACQ CRP | UNIT 09/01/2026 | 0.75% | $583,000 | 57.7K |
| 42 | BRICKELL BIOTECH INC | COM | 0.75% | $580,000 | 2.53M |
| 43 | MAGELLAN HEALTH INC | COM NEW | 0.71% | $551,000 | 5.8K |
| 44 | VRAYQVIEWRAY INC | COM | 0.70% | $545,000 | 99.0K |
| 45 | ROYAL DUTCH SHELL PLC | SPONS ADR A | 0.67% | $521,000 | 12.0K |
| 46 | FOUNDER SPAC | UNIT 07/15/2028 | 0.67% | $518,000 | 50.0K |
| 47 | GRAF ACQUISITION CORP IV | COM | 0.67% | $518,000 | 53.7K |
| 48 | RIGEL PHARMACEUTICALS INC | COM NEW | 0.65% | $504,000 | 190.0K |
| 49 | BATTERY FUTURE ACQUISITION C | UNIT 99/99/9999 | 0.64% | $500,000 | 50.0K |
| 50 | BKOBLUEROCK RESIDENTIAL GWT REI | COM CL A | 0.63% | $489,000 | 18.5K |
| 51 | SCYNEXIS INC | COM NEW | 0.61% | $470,000 | 77.0K |
| 52 | CRVSCORVUS PHARMACEUTICALS INC | COM | 0.60% | $465,000 | 192.9K |
| 53 | VIACOMCBS INC | CL B | 0.59% | $459,000 | 15.2K |
| 54 | MARKETWISE INC | COM CL A | 0.57% | $441,000 | 58.5K |
| 55 | ACRSACLARIS THERAPEUTICS INC | COM | 0.56% | $436,000 | 30.0K |
| 56 | SANBANCO SANTANDER S.A. | ADR | 0.56% | $434,000 | 132.0K |
| 57 | AGILE GROWTH CORP | CLASS A ORD · *W EXP 03/09/202 | 0.56% | $431,000 | 92.3K |
| 58 | GLDSPDR GOLD TR | GOLD SHS | 0.55% | $427,000 | 2.5K |
| 59 | LISTED FD TR | ROUNDHILL SPORTS | 0.54% | $422,000 | 17.0K |
| 60 | CCMPCMC MATERIALS INC | COM | 0.54% | $422,000 | 2.2K |
| 61 | FCXFREEPORT-MCMORAN INC | CL B | 0.54% | $421,000 | 10.1K |
| 62 | GMGENERAL MTRS CO | COM | 0.53% | $412,000 | 7.0K |
| 63 | ATHENE HOLDING LTD | CL A | 0.53% | $408,000 | 4.9K |
| 64 | BRIDGETOWN HOLDINGS LTD | COM CL A | 0.52% | $403,000 | 41.0K |
| 65 | BPBP PLC | SPONSORED ADR | 0.48% | $373,000 | 14.0K |
| 66 | TAT&T INC | COM | 0.48% | $369,000 | 15.0K |
| 67 | ADMAADMA BIOLOGICS INC | COM | 0.47% | $367,000 | 260.0K |
| 68 | CONTRAFECT CORP | COM NEW | 0.47% | $366,000 | 139.0K |
| 69 | HUMANIGEN INC | COM NEW | 0.47% | $366,000 | 98.5K |
| 70 | MOTIVE CAPITAL CORP | SHS CL A | 0.46% | $354,000 | 36.0K |
| 71 | NEOPHOTONICS CORP | COM | 0.46% | $354,000 | 23.0K |
| 72 | UPHEALTH INC | COM | 0.44% | $342,000 | 152.5K |
| 73 | TDCTERADATA CORP DEL | COM | 0.44% | $340,000 | 8.0K |
| 74 | MAKEMYTRIP LIMITED MAURITIUS | SHS | 0.43% | $333,000 | 12.0K |
| 75 | GLOBAL PARTNER ACQISTN CORP | CL A SHS | 0.42% | $328,000 | 33.8K |
| 76 | KORE GROUP HOLDINGS INC | COMMON STOCK | 0.42% | $324,000 | 48.0K |
| 77 | BELLEROPHON THERAPEUTICS INC | COM NEW | 0.41% | $319,000 | 102.8K |
| 78 | JPMJPMORGAN CHASE & CO | COM | 0.41% | $317,000 | 2.0K |
| 79 | DXJWISDOMTREE TR | JAPN HEDGE EQT | 0.40% | $313,000 | 5.0K |
| 80 | VZVERIZON COMMUNICATIONS INC | COM | 0.40% | $312,000 | 6.0K |
| 81 | CEROWPHOENIX BIOTECH ACQUISITION | CLASS A COM · *W EXP 09/01/202 | 0.40% | $311,000 | 46.0K |
| 82 | EENI S P A | SPONSORED ADR | 0.39% | $304,000 | 11.0K |
| 83 | MSFTMICROSOFT CORP | COM | 0.39% | $303,000 | 901 |
| 84 | TTENTOTALENERGIES SE | SPONSORED ADS | 0.38% | $297,000 | 6.0K |
| 85 | TEEKAY LNG PARTNERS L P | PRTNRSP UNITS | 0.38% | $295,000 | 17.4K |
| 86 | METAMETA PLATFORMS INC | CL A | 0.37% | $286,000 | 850 |
| 87 | ERICERICSSON | ADR B SEK 10 | 0.36% | $283,000 | 26.0K |
| 88 | SNAPSNAP INC | CL A | 0.36% | $282,000 | 6.0K |
| 89 | MUSTANG BIO INC | COM | 0.36% | $282,000 | 170.0K |
| 90 | MUMICRON TECHNOLOGY INC | COM | 0.36% | $279,000 | 3.0K |
| 91 | MSOSADVISORSHARES TR | PURE US CANNABIS | 0.35% | $269,000 | 10.5K |
| 92 | STLSTERLING BANCORP DEL | COM | 0.34% | $266,000 | 10.3K |
| 93 | WFCWELLS FARGO CO NEW | COM | 0.34% | $265,000 | 5.5K |
| 94 | NEMNEWMONT CORP | COM | 0.33% | $260,000 | 4.2K |
| 95 | MONEYLION INC | CL A · *W EXP 09/22/202 | 0.33% | $256,000 | 137.7K |
| 96 | XLFSELECT SECTOR SPDR TR | FINANCIAL | 0.33% | $254,000 | 6.5K |
| 97 | ESPRESPERION THERAPEUTICS INC NE | COM | 0.32% | $252,000 | 50.5K |
| 98 | ARENA PHARMACEUTICALS INC | COM NEW | 0.32% | $251,000 | 2.7K |
| 99 | EVE MOBILITY ACQUISITION COR | UNIT 99/99/9999 | 0.32% | $250,000 | 25.0K |
| 100 | AMZNAMAZON COM INC | COM | 0.32% | $250,000 | 75 |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2022 | Under review | 146 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $78M | 177 | Nov 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $84M | 177 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $63M | 165 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $78M | 178 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $74M | 160 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $73M | 139 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $88M | 126 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $59M | 89 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $46M | 73 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $37M | 65 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $29M | 54 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $30M | 41 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $35M | 53 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $129M | 82 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $197M | 101 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $157M | 136 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.